ÂÜÀòÂÒÂ×

Mr. Renft oversees Product Applications for accounts in North America. He works with customers to optimize workflows using recombinant, scalable and sustainable technologies. He facilitate the implementation of InVitria products in cell and gene therapies, vaccines, medical devices, and biologic formulation. Before joining InVitria, he had responsibility for commercial activities within the Interventional division of Becton, Dickinson and Company. There he worked with clinicians to deliver bio surgical devices for patients. Mr. Renft received his Bachelor of Science in Molecular, Cellular, and Developmental Biology with a Minor in Business from the University of Kansas.